RxDoctor Payments Data

Rose Ebel, DO

Family Medicine · Lebanon, OHNPI 1619950656

Payments from drug & device makers

$831in general payments, 2019–2025

Across 45 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$342
  • Lilly USA, LLC$98
  • Novo Nordisk$95
  • Boehringer Ingelheim$75
  • Abbott$48
  • AstraZeneca$35
  • plus $138 from 7 others

What the payments were for

  • Food & beverage$831100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$831 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$61,239
Medicare patients
215
Services billed
934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$63,904
JanuviaSitagliptin Phosphate25$35,973
XareltoRivaroxaban21$31,033
OxycontinOxycodone Hcl18$29,778
TrulicityDulaglutide17$28,941
EliquisApixaban17$22,648
JardianceEmpagliflozin11$15,575
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$13,625
Lurasidone Hcl23$8,207
MyrbetriqMirabegron22$7,050
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$6,182
SymbicortBudesonide/Formoterol Fumarate17$3,734
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$3,018
Gabapentin156$2,896
Omeprazole228$2,710

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$95$63,90445 claims
Lilly USA, LLCTrulicity$98$28,94117 claims
PfizerEliquis$11$22,64817 claims
AstraZenecaBreztri Aerosphere, Symbicort$35$17,35938 claims
Boehringer IngelheimJardiance$75$15,57511 claims
AbbVieSynthroid$342$1,53823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Lebanon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →